Internship at NovoArc

The visit provided a valuable opportunity for an in-depth exchange on academic training, innovation, and the critical role of close collaboration between universities and industry.

At NovoArc, we strongly believe that bridging academic knowledge with applied research and industrial practice is essential for driving meaningful innovation in biotechnology. Hosting students and maintaining an active dialogue with academic partners allows us to contribute to talent development while also benefiting from fresh perspectives and emerging scientific ideas.

We would like to thank Prof. Klausgraber for the insightful discussion and his visit, and we extend our appreciation to Ema for her dedication and excellent work. We look forward to continuing to strengthen our collaboration with academic institutions and supporting the next generation of biotech professionals.

 

News

Nanoparticle Formulation Symposium 2025

We were pleased to contribute to the Nanoparticle Formulation Symposium in London as an invited speaker, sharing insights into current and emerging approaches in nanoparticle development.

Read more

A Great Conversation on the Austrian Patent Office Podcast

We would like to thank the team at the Austrian Patent Office, and in particular Julia Zach, for the kind invitation to participate in the podcast and for the engaging and insightful conversation.

Read more

mRNA Health Conference 2025

NovoArc GmbH is joining forces to advance the next generation of lipid innovation.

Read more

BIO-Europe 2025

We were pleased to attend BIO-Europe, where we connected with partners and stakeholders from across the global biotechnology landscape.

Read more

CPHI Frankfurt 2025

We were pleased to attend CPHI Frankfurt, connecting with stakeholders across the pharmaceutical ecosystem, from drug development and formulation to manufacturing and supply chain solutions.

Read more

Biotech Austria Summit 2025

Biotech Austria Summit, a key platform for connecting startups, technology providers, investors, and industry stakeholders across the Austrian biotechnology ecosystem.

Read more